Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Experimental & Clinical Cancer Research : CR
|
August 29, 2020
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome
Fabio Pelle, Sonia Cappelli, Franco Graziano, et al.
Cancers
|
August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.
Cancers
|
August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Cancers
|
October 14, 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study
Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, et al.
Biology Direct
|
June 23, 2025
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
NPJ Breast Cancer
|
May 29, 2026
Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study
Eriseld Krasniqi, Anna Di Benedetto, Lorena Filomeno, et al.
Cancers
|
December 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2022
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
Laura Pizzuti, Eriseld Krasniqi, Isabella Sperduti, et al.
Frontiers in Oncology
|
June 1, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from <i>CaRe</i>, a multicentric, observational study
Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Experimental & Clinical Cancer Research : CR
|
August 29, 2020
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome
Fabio Pelle, Sonia Cappelli, Franco Graziano, et al.
Cancers
|
August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.
Cancers
|
August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Cancers
|
October 14, 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study
Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, et al.
Biology Direct
|
June 23, 2025
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
NPJ Breast Cancer
|
May 29, 2026
Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study
Eriseld Krasniqi, Anna Di Benedetto, Lorena Filomeno, et al.
Cancers
|
December 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2022
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
Laura Pizzuti, Eriseld Krasniqi, Isabella Sperduti, et al.
Frontiers in Oncology
|
June 1, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from <i>CaRe</i>, a multicentric, observational study
Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, et al.
Page
of 2